• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Randomized trial comparing a stent-avoiding with a stent-preferred strategy in complex femoropopliteal lesions.

作者信息

Sufali Gemmi, Teraa Martin

机构信息

Department of Vascular Surgery, University Medical Center Utrecht, Utrecht, The Netherlands.

Vascular Surgery, Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna, Italy.

出版信息

Cardiovasc Diagn Ther. 2024 Dec 31;14(6):1011-1014. doi: 10.21037/cdt-24-384. Epub 2024 Dec 12.

DOI:10.21037/cdt-24-384
PMID:39790186
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11707465/
Abstract
摘要

相似文献

1
Randomized trial comparing a stent-avoiding with a stent-preferred strategy in complex femoropopliteal lesions.在复杂股腘动脉病变中比较避免使用支架与优先使用支架策略的随机试验。
Cardiovasc Diagn Ther. 2024 Dec 31;14(6):1011-1014. doi: 10.21037/cdt-24-384. Epub 2024 Dec 12.
2
Randomized Trial Comparing a Stent-Avoiding With a Stent-Preferred Strategy in Complex Femoropopliteal Lesions.随机对照试验比较在复杂股腘动脉病变中避免支架与支架优先策略。
JACC Cardiovasc Interv. 2024 May 13;17(9):1134-1144. doi: 10.1016/j.jcin.2024.03.015.
3
Bare metal stent versus paclitaxel eluting stent for intermediate length femoropopliteal arterial lesions (BATTLE trial): study protocol for a randomized controlled trial.裸金属支架与紫杉醇洗脱支架治疗中等长度股腘动脉病变的比较（BATTLE试验）：一项随机对照试验的研究方案
Trials. 2014 Oct 30;15:423. doi: 10.1186/1745-6215-15-423.
4
Cost-effectiveness of a paclitaxel-eluting stent (Eluvia) compared to Zilver PTX for endovascular femoropopliteal intervention.紫杉醇洗脱支架（Eluvia）与 Zilver PTX 用于血管内股腘动脉介入治疗的成本效益比较。
J Med Econ. 2022 Jan-Dec;25(1):880-887. doi: 10.1080/13696998.2022.2088965.
5
Efficacy of a Drug-Eluting Stent Versus Bare Metal Stents for Symptomatic Femoropopliteal Peripheral Artery Disease: Primary Results of the EMINENT Randomized Trial.药物洗脱支架与裸金属支架治疗症状性股腘动脉周围动脉疾病的疗效：EMINENT 随机试验的主要结果。
Circulation. 2022 Nov 22;146(21):1564-1576. doi: 10.1161/CIRCULATIONAHA.122.059606. Epub 2022 Oct 18.
6
A Systematic Review and Meta-Analysis of Efficacy and Safety of Cilostazol Prescription in Patients With Femoropopliteal Peripheral Artery Disease After Endovascular Therapy.西洛他唑处方用于血管腔内治疗后股腘动脉外周动脉疾病患者的疗效和安全性的系统评价与Meta分析
J Endovasc Ther. 2024 Apr 9:15266028241241248. doi: 10.1177/15266028241241248.
7
Heparin-bonded covered stents versus bare-metal stents for complex femoropopliteal artery lesions: the randomized VIASTAR trial (Viabahn endoprosthesis with PROPATEN bioactive surface [VIA] versus bare nitinol stent in the treatment of long lesions in superficial femoral artery occlusive disease).肝素结合涂层支架与裸金属支架治疗复杂股腘动脉病变的随机对照试验（Viabahn 覆膜支架联合 PROPATEN 生物活性表面[VIA]与裸钽支架治疗股浅动脉闭塞性疾病长段病变的疗效比较[VIASTAR 试验]）。
J Am Coll Cardiol. 2013 Oct 8;62(15):1320-7. doi: 10.1016/j.jacc.2013.05.079. Epub 2013 Jul 10.
8
Intravascular Lithotripsy for Peripheral Artery Calcification: 30-Day Outcomes From the Randomized Disrupt PAD III Trial.血管内碎石术治疗外周动脉钙化：随机 Disrupt PAD III 试验的 30 天结果。
JACC Cardiovasc Interv. 2021 Jun 28;14(12):1352-1361. doi: 10.1016/j.jcin.2021.04.010.
9
A Polymer-Free Paclitaxel-Eluting Stent Versus a Bare-Metal Stent for De Novo Femoropopliteal Lesions: The BATTLE Trial.载紫杉醇聚合物涂层支架与裸金属支架治疗首发股浅动脉病变的比较：BATTLE 试验
JACC Cardiovasc Interv. 2020 Feb 24;13(4):447-457. doi: 10.1016/j.jcin.2019.12.028.
10
Retrospective Multicenter Comparison Between Viabahn Covered Stent-Grafts and Supera Interwoven Nitinol Stents for Endovascular Treatment in Severely Calcified Femoropopliteal Artery Disease: The ARMADILLO Study (Adjusted Retrospective coMparison of scAffolDs In caLcified LesiOns).回顾性多中心比较 Viabahn 覆膜支架和 Supera 编织型镍钛合金支架治疗严重钙化股腘动脉病变的疗效：ARMADILLO 研究（调整后的回顾性比较支架在钙化病变中的应用）。
J Endovasc Ther. 2024 Jun;31(3):400-409. doi: 10.1177/15266028221124727. Epub 2022 Sep 22.

本文引用的文献

1
Beyond the classic major cardiovascular event outcome for cardiovascular trials.超越心血管试验的经典主要心血管事件结局。
Eur Heart J. 2024 Nov 21;45(44):4700-4703. doi: 10.1093/eurheartj/ehae478.
2
Randomized Trial Comparing a Stent-Avoiding With a Stent-Preferred Strategy in Complex Femoropopliteal Lesions.随机对照试验比较在复杂股腘动脉病变中避免支架与支架优先策略。
JACC Cardiovasc Interv. 2024 May 13;17(9):1134-1144. doi: 10.1016/j.jcin.2024.03.015.
3
Artificial intelligence-based predictive models in vascular diseases.基于人工智能的血管疾病预测模型。
Semin Vasc Surg. 2023 Sep;36(3):440-447. doi: 10.1053/j.semvascsurg.2023.05.002. Epub 2023 May 27.
4
Twelve-Month Outcomes of Intravascular Lithotripsy for Treatment of Calcified Popliteal and Infrapopliteal Lesions in Patients With Chronic Limb-Threatening Ischemia.血管内碎石术治疗慢性肢体威胁性缺血患者钙化腘动脉和腘下病变的12个月结果
J Endovasc Ther. 2023 Oct 18:15266028231205421. doi: 10.1177/15266028231205421.
5
Assessing Limb Outcomes in Drug Trials in Peripheral Artery Disease: The Need for a Universal and Pragmatic Definition.评估外周动脉疾病药物试验中的肢体预后：对通用且实用定义的需求。
Eur J Vasc Endovasc Surg. 2023 Sep;66(3):442-443. doi: 10.1016/j.ejvs.2023.06.007. Epub 2023 Jun 15.
6
Comparing the impact of the loss of patency between treatment with drug-coated balloon angioplasty and drug-eluting stent placement.比较药物涂层球囊血管成形术和药物洗脱支架置入治疗后再狭窄的影响。
J Vasc Surg. 2023 Jun;77(6):1751-1759. doi: 10.1016/j.jvs.2023.01.207. Epub 2023 Feb 14.
7
Superficial Femoral Artery Endovascular Therapy: 12-Month Primary Patency Rates of Contemporary Endovascular Devices from 25,051 Patients.股浅动脉腔内治疗：25051 例患者采用当代腔内器械的 12 个月一期通畅率。
J Invasive Cardiol. 2022 Nov;34(11):E784-E792. doi: 10.25270/jic/22.00149. Epub 2022 Oct 21.
8
Algorithm of Femoropopliteal Endovascular Treatment.股腘动脉腔内治疗的算法。
Medicina (Kaunas). 2022 Sep 16;58(9):1293. doi: 10.3390/medicina58091293.
9
Peripheral Artery Disease Intervention: Drug-Coated Balloon vs Drug-Eluting Stent, A Long-Term Comparison.外周动脉疾病介入治疗：药物涂层球囊与药物洗脱支架的长期比较。
J Interv Cardiol. 2022 Aug 27;2022:5175607. doi: 10.1155/2022/5175607. eCollection 2022.
10
Vessel Preparation in Infrapopliteal Arterial Disease: A Systematic Review and Meta-Analysis.《主-髂动脉疾病腔内治疗中国专家共识》要点 **关键词**：主-髂动脉疾病；腔内治疗；专家共识 **摘要**：目的 对主-髂动脉疾病腔内治疗的中国专家共识进行总结，为临床实践提供指导。方法 采用循证医学的方法，对国内外发表的相关文献进行检索和分析，结合专家的临床经验和意见，制定了共识的推荐意见。结果 共识共包括 23 条推荐意见，涵盖了主-髂动脉疾病的流行病学、诊断、治疗策略、腔内治疗技术、围手术期管理等方面。结论 本共识为中国医生提供了主-髂动脉疾病腔内治疗的规范化建议，有助于提高治疗效果和改善患者预后。
J Endovasc Ther. 2024 Apr;31(2):191-202. doi: 10.1177/15266028221120752. Epub 2022 Sep 4.